Therapeutic guidelines and side effects encountered during L-dopa therapy in 100 cases of parkinsonism.
D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors; D002940:Circadian Rhythm; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000009:adverse effects*; D004351:Drug Resistance; D005260:Female; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006236:Handwriting; D006801:Humans; D007022:Hypotension / Q000139:chemically induced; D009069:Movement Disorders / Q000139:chemically induced; D010300:Parkinson Disease / Q000188:drug therapy*; D011292:Premedication; D013997:Time Factors
D004295:Dihydroxyphenylalanine; D002262:Carboxy-Lyases